Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer

Aung Ko Win(The University of Melbourne), Mark A. Jenkins(The University of Melbourne), James G. Dowty(The University of Melbourne), Antonis C. Antoniou(Cancer Research UK Cambridge Center), Andrew Lee(Cancer Research UK Cambridge Center), Graham G. Giles(The University of Melbourne), Daniel D. Buchanan(The University of Melbourne), Mark Clendenning(The University of Melbourne), Christophe Rosty(QIMR Berghofer Medical Research Institute), Dennis J. Ahnen(University of Colorado Denver), Stephen N. Thibodeau(Mayo Clinic), Graham Casey(Virginia Department of Health), Steven Gallinger(Lunenfeld-Tanenbaum Research Institute), Loı̈c Le Marchand(Cancer Center of Hawaii), Robert W. Haile(Stanford University), John D. Potter(University of Washington), Yingye Zheng(University of Washington), Noralane M. Lindor(Mayo Clinic in Arizona), Polly A. Newcomb(University of Washington), John L. Hopper(The University of Melbourne), Robert J. MacInnis(The University of Melbourne)
Cancer Epidemiology Biomarkers & Prevention
October 31, 2016
Cited by 519Open Access
Full Text

Abstract

Abstract Background: Although high-risk mutations in identified major susceptibility genes (DNA mismatch repair genes and MUTYH) account for some familial aggregation of colorectal cancer, their population prevalence and the causes of the remaining familial aggregation are not known. Methods: We studied the families of 5,744 colorectal cancer cases (probands) recruited from population cancer registries in the United States, Canada, and Australia and screened probands for mutations in mismatch repair genes and MUTYH. We conducted modified segregation analyses using the cancer history of first-degree relatives, conditional on the proband's age at diagnosis. We estimated the prevalence of mutations in the identified genes, the prevalence of HR for unidentified major gene mutations, and the variance of the residual polygenic component. Results: We estimated that 1 in 279 of the population carry mutations in mismatch repair genes (MLH1 = 1 in 1,946, MSH2 = 1 in 2,841, MSH6 = 1 in 758, PMS2 = 1 in 714), 1 in 45 carry mutations in MUTYH, and 1 in 504 carry mutations associated with an average 31-fold increased risk of colorectal cancer in unidentified major genes. The estimated polygenic variance was reduced by 30% to 50% after allowing for unidentified major genes and decreased from 3.3 for age <40 years to 0.5 for age ≥70 years (equivalent to sibling relative risks of 5.1 to 1.3, respectively). Conclusions: Unidentified major genes might explain one third to one half of the missing heritability of colorectal cancer. Impact: Our findings could aid gene discovery and development of better colorectal cancer risk prediction models. Cancer Epidemiol Biomarkers Prev; 26(3); 404–12. ©2016 AACR.


Related Papers

No related papers found

Powered by citation graph analysis